Eden Studios, Inc. is an American role-playing game publisher founded in 1996, Eden Studios is best known for the Buffyverse role-playing games - the "Buffy the Vampire Slayer" and "Angel" role-playing games - are complementary, officially licensed role-playing games (RPGs) published by Eden Studios, Inc, The "Buffy the Vampire Slayer Core Rulebook", was published in what year?
Buffyverse role-playing games The Buffyverse role-playing games - the "Buffy the Vampire Slayer" and "Angel" role-playing games - are complementary, officially licensed role-playing games (RPGs) published by Eden Studios, Inc. The "Buffy the Vampire Slayer Core Rulebook" was published in 2002, while the "Angel Corebook" followed in 2003. Both games use a streamlined (or "Cinematic") version of Eden Studios' popular "Unisystem" game engine, also featured in "CJ Carella's WitchCraft" and "All Flesh Must Be Eaten", two of Eden's better-known original product lines. In both games, players are able to take on the roles of characters from the respective television series or create wholly original characters as they and their group see fit, effectively building their own Buffyverse series in the process.
Aberrant Aberrant is a role-playing game created by White Wolf Game Studio in 1999, set in 2008 in a world where super-powered humans started appearing one day in 1998. It is the middle setting in the greater Trinity Universe timeline, chronologically situated about 90 years after "Adventure!", White Wolf's Pulp era game, and over a century before the psionic escapades of "Trinity/Aeon". The game deals with how the players' meta-human characters (called "novas") fit into a mundane world when they most definitely are "not" mundane, as well as how the mundane populace react to the sudden emergence of novas. The original "Aberrant" product line was discontinued in 2002, though a d20 System version was released in 2004. Onyx Path Publishing has recently acquired the rights to the Trinity Universe and has announced its intention to release a new edition of "Aberrant".